[JSNP Excellent Presentation Award for AsCNP 2011: improvement of cognitive impairments on withdrawal after repeated methamphetamine by administration of a cannabinoid CB1 receptor antagonist and a COX inhibitor].
Y
Y
Nawata
T
T
Yamaguchi
T
T
Yamamoto
D000818:Animals; D001363:Awards and Prizes; D003072:Cognition Disorders / Q000139:chemically induced / Q000188:drug therapy*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004008:Diclofenac / Q000627:therapeutic use*; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D051379:Mice; D008813:Mice, Inbred ICR; D018345:Mice, Knockout; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D016861:Cyclooxygenase Inhibitors; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D004008:Diclofenac; C103505:AM 251; D008694:Methamphetamine